What is the current valuation of the Animal Model Market as of 2024?

The market was valued at 2777.94 USD Million in 2024. Read More

What is the projected market size for the market by 2035?

The market is projected to reach 5919.84 USD Million by 2035. Read More

What is the expected CAGR for the Animal Model Market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 7.12%. Read More

Which application segments are driving growth in the Animal Model Market?

Key application segments include Drug Discovery, Toxicology Testing, and Regenerative Medicine, with valuations ranging from 600.0 to 1519.84 USD Million. Read More

What types of animal models are most commonly used in research?

Mice and rats are the most commonly used animal models, with market valuations between 500.0 and 1300.0 USD Million. Read More

Which research areas are seeing the highest investment in the Animal Model Market?

Oncology and Neurology are leading research areas, with market valuations reaching up to 1300.0 USD Million. Read More

Who are the key players in the market?

Key players include Charles River Laboratories, Envigo, and The Jackson Laboratory, among others. Read More

What are the primary end users of animal models in research?

Pharmaceutical companies and biotechnology firms are the primary end users, with market valuations between 555.09 and 2390.0 USD Million. Read More

How does the market for non-human primates compare to other animal types?

The market for non-human primates is valued between 400.0 and 800.0 USD Million, which is lower than that of mice and rats. Read More

What trends are influencing the growth of the Animal Model Market?

Trends such as advancements in genetic research and increasing demand for regenerative medicine are likely influencing market growth. Read More

Animal Model Market

ID: MRFR/Pharma/8231-HCR

140 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Animal Model Market Research Report Information By Animal Type (Pigs, Cats, and Mice), By Technology (CRISPR, Microinjection, and Embryonic Stem Cell Injection), By Application (Research & Development, Production, and Quality Control), By End-User (Research Institutes, Educational Institutes, Pharmaceutical Companies, and Contract Research Organizations), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Drug Discovery | |
  2. 4.1.2 Toxicology Testing | |
  3. 4.1.3 Genetic Research | |
  4. 4.1.4 Disease Modeling | |
  5. 4.1.5 Regenerative Medicine |
2. 4.2 Healthcare, BY Type of Animal Model (USD Million) | |
  1. 4.2.1 Mice | |
  2. 4.2.2 Rats | |
  3. 4.2.3 Non-Human Primates | |
  4. 4.2.4 Zebrafish | |
  5. 4.2.5 Guinea Pigs |
3. 4.3 Healthcare, BY Research Area (USD Million) | |
  1. 4.3.1 Oncology | |
  2. 4.3.2 Neurology | |
  3. 4.3.3 Cardiology | |
  4. 4.3.4 Immunology | |
  5. 4.3.5 Metabolic Disorders |
4. 4.4 Healthcare, BY End User (USD Million) | |
  1. 4.4.1 Pharmaceutical Companies | |
  2. 4.4.2 Biotechnology Firms | |
  3. 4.4.3 Academic Institutions | |
  4. 4.4.4 Contract Research Organizations | |
  5. 4.4.5 Government Research Laboratories |
5. 4.5 Healthcare, BY Region (USD Million) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Charles River Laboratories (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Envigo (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Taconic Biosciences (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Harlan Laboratories (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Crown Bioscience (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Janvier Labs (FR) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 The Jackson Laboratory (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Wuxi AppTec (CN) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Inotiv (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
8. 6.5 US MARKET ANALYSIS BY RESEARCH AREA |
9. 6.6 US MARKET ANALYSIS BY END USER |
10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
11. 6.8 CANADA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
12. 6.9 CANADA MARKET ANALYSIS BY RESEARCH AREA |
13. 6.10 CANADA MARKET ANALYSIS BY END USER |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
16. 6.13 GERMANY MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
17. 6.14 GERMANY MARKET ANALYSIS BY RESEARCH AREA |
18. 6.15 GERMANY MARKET ANALYSIS BY END USER |
19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
20. 6.17 UK MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
21. 6.18 UK MARKET ANALYSIS BY RESEARCH AREA |
22. 6.19 UK MARKET ANALYSIS BY END USER |
23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
24. 6.21 FRANCE MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
25. 6.22 FRANCE MARKET ANALYSIS BY RESEARCH AREA |
26. 6.23 FRANCE MARKET ANALYSIS BY END USER |
27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
28. 6.25 RUSSIA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
29. 6.26 RUSSIA MARKET ANALYSIS BY RESEARCH AREA |
30. 6.27 RUSSIA MARKET ANALYSIS BY END USER |
31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
32. 6.29 ITALY MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
33. 6.30 ITALY MARKET ANALYSIS BY RESEARCH AREA |
34. 6.31 ITALY MARKET ANALYSIS BY END USER |
35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
36. 6.33 SPAIN MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
37. 6.34 SPAIN MARKET ANALYSIS BY RESEARCH AREA |
38. 6.35 SPAIN MARKET ANALYSIS BY END USER |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY RESEARCH AREA |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
45. 6.42 CHINA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
46. 6.43 CHINA MARKET ANALYSIS BY RESEARCH AREA |
47. 6.44 CHINA MARKET ANALYSIS BY END USER |
48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
49. 6.46 INDIA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
50. 6.47 INDIA MARKET ANALYSIS BY RESEARCH AREA |
51. 6.48 INDIA MARKET ANALYSIS BY END USER |
52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
53. 6.50 JAPAN MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
54. 6.51 JAPAN MARKET ANALYSIS BY RESEARCH AREA |
55. 6.52 JAPAN MARKET ANALYSIS BY END USER |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY RESEARCH AREA |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER |
60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
61. 6.58 MALAYSIA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
62. 6.59 MALAYSIA MARKET ANALYSIS BY RESEARCH AREA |
63. 6.60 MALAYSIA MARKET ANALYSIS BY END USER |
64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
65. 6.62 THAILAND MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
66. 6.63 THAILAND MARKET ANALYSIS BY RESEARCH AREA |
67. 6.64 THAILAND MARKET ANALYSIS BY END USER |
68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
69. 6.66 INDONESIA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
70. 6.67 INDONESIA MARKET ANALYSIS BY RESEARCH AREA |
71. 6.68 INDONESIA MARKET ANALYSIS BY END USER |
72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
73. 6.70 REST OF APAC MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
74. 6.71 REST OF APAC MARKET ANALYSIS BY RESEARCH AREA |
75. 6.72 REST OF APAC MARKET ANALYSIS BY END USER |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
78. 6.75 BRAZIL MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
79. 6.76 BRAZIL MARKET ANALYSIS BY RESEARCH AREA |
80. 6.77 BRAZIL MARKET ANALYSIS BY END USER |
81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
82. 6.79 MEXICO MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
83. 6.80 MEXICO MARKET ANALYSIS BY RESEARCH AREA |
84. 6.81 MEXICO MARKET ANALYSIS BY END USER |
85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
86. 6.83 ARGENTINA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
87. 6.84 ARGENTINA MARKET ANALYSIS BY RESEARCH AREA |
88. 6.85 ARGENTINA MARKET ANALYSIS BY END USER |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY RESEARCH AREA |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY RESEARCH AREA |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY RESEARCH AREA |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER |
102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
103. 6.100 REST OF MEA MARKET ANALYSIS BY TYPE OF ANIMAL MODEL |
104. 6.101 REST OF MEA MARKET ANALYSIS BY RESEARCH AREA |
105. 6.102 REST OF MEA MARKET ANALYSIS BY END USER |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
114. 6.111 HEALTHCARE, BY TYPE OF ANIMAL MODEL, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY TYPE OF ANIMAL MODEL, 2024 TO 2035 (USD Million) |
116. 6.113 HEALTHCARE, BY RESEARCH AREA, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY RESEARCH AREA, 2024 TO 2035 (USD Million) |
118. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.2.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.3.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.3.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.3.4 BY END USER, 2025-2035 (USD Million) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.4.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.4.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.4.4 BY END USER, 2025-2035 (USD Million) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.5.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.5.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.5.4 BY END USER, 2025-2035 (USD Million) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.6.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.6.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.6.4 BY END USER, 2025-2035 (USD Million) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.7.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.7.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.7.4 BY END USER, 2025-2035 (USD Million) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.8.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.8.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.8.4 BY END USER, 2025-2035 (USD Million) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.9.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.9.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.9.4 BY END USER, 2025-2035 (USD Million) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.10.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.10.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.10.4 BY END USER, 2025-2035 (USD Million) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.11.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.11.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.11.4 BY END USER, 2025-2035 (USD Million) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.12.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.12.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.12.4 BY END USER, 2025-2035 (USD Million) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.13.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.13.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.13.4 BY END USER, 2025-2035 (USD Million) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.14.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.14.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.14.4 BY END USER, 2025-2035 (USD Million) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.15.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.15.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.15.4 BY END USER, 2025-2035 (USD Million) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.16.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.16.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.16.4 BY END USER, 2025-2035 (USD Million) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.17.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.17.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.17.4 BY END USER, 2025-2035 (USD Million) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.18.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.18.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.18.4 BY END USER, 2025-2035 (USD Million) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.19.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.19.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.19.4 BY END USER, 2025-2035 (USD Million) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.20.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.20.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.20.4 BY END USER, 2025-2035 (USD Million) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.21.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.21.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.21.4 BY END USER, 2025-2035 (USD Million) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.22.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.22.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.22.4 BY END USER, 2025-2035 (USD Million) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.23.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.23.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.23.4 BY END USER, 2025-2035 (USD Million) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.24.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.24.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.24.4 BY END USER, 2025-2035 (USD Million) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.25.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.25.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.25.4 BY END USER, 2025-2035 (USD Million) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.26.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.26.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.26.4 BY END USER, 2025-2035 (USD Million) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.27.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.27.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.27.4 BY END USER, 2025-2035 (USD Million) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.28.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.28.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.28.4 BY END USER, 2025-2035 (USD Million) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.29.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.29.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.29.4 BY END USER, 2025-2035 (USD Million) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.30.2 BY TYPE OF ANIMAL MODEL, 2025-2035 (USD Million) | |
  3. 7.30.3 BY RESEARCH AREA, 2025-2035 (USD Million) | |
  4. 7.30.4 BY END USER, 2025-2035 (USD Million) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Drug Discovery
Toxicology Testing
Genetic Research
Disease Modeling
Regenerative Medicine

Healthcare By Type of Animal Model (USD Million, 2025-2035)

Mice
Rats
Non-Human Primates
Zebrafish
Guinea Pigs

Healthcare By Research Area (USD Million, 2025-2035)

Oncology
Neurology
Cardiology
Immunology
Metabolic Disorders

Healthcare By End User (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Firms
Academic Institutions
Contract Research Organizations
Government Research Laboratories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓